medsurfnews - glucose-insulin-potassium therapy in patients with st-segment elevation myocardial infarction

Cardiology

Glucose-Insulin-Potassium Therapy in Patients With ST-Segment Elevation Myocardial Infarction

The clinical benefit of glucose-insulin-potassium (GIK) infusion in patients with ST-segment elevation myocardial infarction (STEMI) is unclear. While some smaller trials suggest benefit, in the CREATE-ECLA trial, GIK infusion had no effect on 30-day mortality in 20 201 patients.
Read more

http://jama.ama-assn.org/cgi/content/short/298/20/2399?rss=1...

Journal of the American Medical Association

Last resources from Journal of the American Medical Association

Autologous Stem Cells in Kidney Transplants (Transplant Surgery)
Papules, Plaques, and Nodules in an Immunocompromised Patient (Dermatology)
Clopidogrel on CYP2C19 Genotype and Effect on Platelet Reactivity in Patients With Stable Cardiovascular Disease (Cardiology)
Association Between Disease-Modifying Antirheumatic Drugs and Diabetes Risk in Patients With Rheumatoid Arthritis and Psoriasis (Diabetology)
Interactive Games to Promote Behavior Change in Prevention and Treatment (General medicine)
View all resources from Journal of the American Medical Association